Advisory: Alert incorrectly tagged to Canadian National Railway withdrawn
12/03/2025 12:20
An alert on Clene Inc CLNN.O announcing results from its clinical drug trial for treatment of amyotrophic lateral sclerosis was inadvertently tagged to Canadian National Railway Co CNR.TO, an unrelated company, and has been withdrawn. There will be no substitute. STORY_NUMBER: nTUA9RFX5T STORY_DATE: 12/03/2025 STORY_TIME: 1200 GMT ((bangalore.newsroom@thomsonreuters.com))
Recent news on Clene
See all newsClene Inc reports results for the quarter ended June 30 - Earnings Summary
Clene Q2 net loss widens on higher other expenses
Clene Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Clene Inc - Enters Second Amendment To Senior Secured Convertible Notes - SEC Filing
Clene Q1 loss widens on warrant liability issuance costs